Notice2022-11171

Notice of Public Meeting of the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) Scientific Advisory Board

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
May 25, 2022

Issuing agencies

State Department

Abstract

In accordance with the Federal Advisory Committee Act, the U.S. Department of State announces that the PEPFAR Scientific Advisory Board (SAB) will be holding a virtual meeting of the full board. The meeting will be open to the public. Pre-registration is required for public participation.

Full Text

<html>
<head>
<title>Federal Register, Volume 87 Issue 101 (Wednesday, May 25, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 101 (Wednesday, May 25, 2022)]
[Notices]
[Pages 31928-31929]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-11171]


-----------------------------------------------------------------------

DEPARTMENT OF STATE

[Public Notice: 11729]


Notice of Public Meeting of the U.S. President's Emergency Plan 
for AIDS Relief (PEPFAR) Scientific Advisory Board

SUMMARY: In accordance with the Federal Advisory Committee Act, the 
U.S. Department of State announces that the PEPFAR Scientific Advisory 
Board (SAB) will be holding a virtual meeting of the full board. The 
meeting will be open to the public. Pre-registration is required for 
public participation.

DATES: The meeting will be held on Tuesday, June 7, 2022, from 
approximately 11:00 a.m. to 1:00 p.m. (EDT) utilizing an online 
platform. Requests to attend the meeting must be received no later than 
May 31, 2022. Requests for reasonable accommodations must be received 
no later than May 31, 2022. Requests made after May 31, 2022, will be 
considered but might not be able to be fulfilled.

ADDRESSES: Individuals wishing to participate are asked to pre-register 
at <a href="https://forms.gle/9TUWqUGjzKXFTFZ17">https://forms.gle/9TUWqUGjzKXFTFZ17</a>. The agenda be sent to all 
registrants and will also be posted on the PEPFAR SAB web page at 
<a href="http://www.state.gov/scientific-advisory-board-pepfar">www.state.gov/scientific-advisory-board-pepfar</a> one week in advance of 
the meeting, along with instructions on how to access the meeting.

FOR FURTHER INFORMATION CONTACT: Dr. Sara Klucking, Designated Federal 
Officer for the SAB, Office of the U.S. Global AIDS Coordinator and 
Health Diplomacy at <a href="/cdn-cgi/l/email-protection#b9f2d5ccdad2d0d7deeaebf9cacdd8cddc97ded6cf"><span class="__cf_email__" data-cfemail="0f44637a6c646661685c5d4f7c7b6e7b6a21686079">[email&#160;protected]</span></a> or (202) 615-4350.

SUPPLEMENTARY INFORMATION: 
    Background: The SAB is established under the general authority of 
the Secretary of State and the Department of State (``the Department'') 
as set forth in 22 U.S.C. 2656, and consistent with the Federal 
Advisory Committee Act, as amended (5 U.S.C. Appendix). The SAB serves 
the U.S. Global AIDS Coordinator solely in an advisory capacity 
concerning scientific, implementation, and policy issues related to the 
global response to HIV/AIDS.
    Agenda: SAB members will be discussing considerations for PEPFAR 
for implementation of long-acting injectable cabotegravir (CAB for 
PrEP) and tools for recent infection monitoring.
    Public comment: Members of the public who wish to participate are 
asked to register directly at the link listed in the ADDRESSES section 
or by sending an email to Dr. Sara Klucking at <a href="/cdn-cgi/l/email-protection#b2f9dec7d1d9dbdcd5e1e0f2c1c6d3c6d79cd5ddc4"><span class="__cf_email__" data-cfemail="9cd7f0e9fff7f5f2fbcfcedcefe8fde8f9b2fbf3ea">[email&#160;protected]</span></a> not 
later than May 31, 2022. Individuals are required to provide their 
name, email address, and organization. Due to time limitations, there 
will not be public comment at the meeting; however, the Department will 
consider any written comments provided within 10 days after

[[Page 31929]]

the meeting to Dr. Sara Klucking at <a href="/cdn-cgi/l/email-protection#bdf6d1c8ded6d4d3daeeeffdcec9dcc9d893dad2cb"><span class="__cf_email__" data-cfemail="feb5928b9d95979099adacbe8d8a9f8a9bd0999188">[email&#160;protected]</span></a>.

Sara Klucking,
Director, Office of Research and Science, Office of the U.S. Global 
AIDS Coordinator and Health Diplomacy, Office of the Secretary of 
State, Department of State.
[FR Doc. 2022-11171 Filed 5-24-22; 8:45 am]
BILLING CODE 4710-10-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Indexed from Federal Register on May 25, 2022.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.